Report overview
Smoking cessation (also known as quitting smoking or simply quitting) is the process of discontinuing tobacco smoking. Tobacco smoke contains nicotine, which is addictive. Nicotine withdrawal makes the process of quitting often very prolonged and difficult.
This report contains market size and forecasts of Smoking Cessation Drugs in global, including the following market information:
Global Smoking Cessation Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Smoking Cessation Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Smoking Cessation Drugs companies in 2021 (%)
The global Smoking Cessation Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
NRTs Products Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Smoking Cessation Drugs include GSK, Pfizer, Kimree Technology, Johnson & Johnson, Novartis, Dr. Reddy's Laboratories, The Harvard Drug Group, Perrigo Company and Fontem Ventures and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Smoking Cessation Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Smoking Cessation Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Smoking Cessation Drugs Market Segment Percentages, by Type, 2021 (%)
NRTs Products
Nicotine-Free Products
Global Smoking Cessation Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Smoking Cessation Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global Smoking Cessation Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Smoking Cessation Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Smoking Cessation Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Smoking Cessation Drugs revenues share in global market, 2021 (%)
Key companies Smoking Cessation Drugs sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Smoking Cessation Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Pfizer
Kimree Technology
Johnson & Johnson
Novartis
Dr. Reddy's Laboratories
The Harvard Drug Group
Perrigo Company
Fontem Ventures
Smoke Away
